Hansa Biopharma AB, ("Hansa" or "the Company"), , today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for imlifidase. The Company is ...
United Natural Foods, Inc. ( UNFI) Q1 2026 Earnings Call December 2, 2025 8:30 AM EST Thank you for standing by, and welcome to the UNFI First Quarter Fiscal 2026 Earnings Conference Call. [Operator ...
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...
There are tons of brilliant open-source apps. You'll find open-source titles for Linux, MacOS, and Windows. Some of these apps are so good, they should have a price tag. Since I started my journey ...
Swiftly's solution delivers value-driven savings across convenience store locations nationwide. As part of the nationwide rollout, these offers will be supported by coordinated in-store signage and ...
AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) in combination with pertuzumab has been approved in the US for the 1st-line treatment of adult patients with unresectable or ...
US stocks opened mixed on Thursday, with a 15% tumble for Oracle which put more tech-exposed gauges under pressure after its earnings reignited AI bubble fears. The FTSE 100 and E ...
I’m not a big fan of the subscription economy. It seems like most apps are trying to get us to pay a monthly — or yearly — subscription these days, a stark contrast to the times when getting full ...
Dr. JeFreda R. Brown is a financial consultant, Certified Financial Education Instructor, and researcher who has assisted thousands of clients over a more than two-decade career. She is the CEO of ...
Two weapons, one mission set, one ballistic brain: the M7 and M250 were built to fight as a paired system so squads can put ...
There has been some unexpected trouble out at aerospace stock Boeing (BA) recently, and over an unexpected source. It has nothing to do with the issues the 737 MAX line has faced, nor the still-behind ...